Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Shohei Nishimon, Naoya Nishino & Seiji Nishino. (2021) Advances in the pharmacological management of non-24-h sleep-wake disorder. Expert Opinion on Pharmacotherapy 22:8, pages 1039-1049.
Read now
Read now
Shohei Nishimon, Mari Nishimon & Seiji Nishino. (2019) Tasimelteon for treating non-24-h sleep-wake rhythm disorder. Expert Opinion on Pharmacotherapy 20:9, pages 1065-1073.
Read now
Read now
Wendy Rydzkowski, Nicola Canale & Louisa Reynolds. (2016) A review of interventions for adolescents with insomnia and the role of the educational and child psychologist: when sleep does not come easily. Educational Psychology in Practice 32:1, pages 24-37.
Read now
Read now
Eliza L Sutton. (2015) Profile of suvorexant in the management of insomnia. Drug Design, Development and Therapy 9, pages 6035-6042.
Read now
Read now
Alessia Carocci, Alessia Catalano & Maria Stefania Sinicropi. (2014) Melatonergic drugs in development. Clinical Pharmacology: Advances and Applications 6, pages 127-137.
Read now
Read now
Ludovit Paulis, Fedor Simko & Moshe Laudon. (2012) Cardiovascular effects of melatonin receptor agonists. Expert Opinion on Investigational Drugs 21:11, pages 1661-1678.
Read now
Read now
Octavian C Ioachimescu & Ali A El-Solh. (2012) Pharmacotherapy of insomnia. Expert Opinion on Pharmacotherapy 13:9, pages 1243-1260.
Read now
Read now
Dieter Kunz, Sébastien Bineau, Khaled Maman, Dominique Milea & Mondher Toumi. (2012) Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database. Expert Opinion on Pharmacotherapy 13:1, pages 9-16.
Read now
Read now
D Alan Lankford. (2011) Tasimelteon for insomnia. Expert Opinion on Investigational Drugs 20:7, pages 987-993.
Read now
Read now
Ben Green. (2011) Focus on agomelatine. Current Medical Research and Opinion 27:4, pages 745-749.
Read now
Read now
Monique AJ Mets, Kenny R van Deventer, Berend Olivier & Joris C Verster. (2010) Critical appraisal of ramelteon in the treatment of insomnia. Nature and Science of Sleep 2, pages 257-266.
Read now
Read now
Rüdiger Hardeland. (2010) Investigational melatonin receptor agonists. Expert Opinion on Investigational Drugs 19:6, pages 747-764.
Read now
Read now
Articles from other publishers (54)
Christine Salahub, Peter E. Wu, Lisa D. Burry, Christine Soong, Kathleen A. Sheehan, Thomas E. MacMillan & Lauren Lapointe-Shaw. (2022) Melatonin for Insomnia in Medical Inpatients: A Narrative Review. Journal of Clinical Medicine 12:1, pages 256.
Crossref
Crossref
Weiwei Chu, Shang Li, Xueying Geng, Dongshuang Wang, Junyu Zhai, Gang Lu, Wai-Yee Chan, Zi-Jiang Chen & Yanzhi Du. (2022) Long-term environmental exposure of darkness induces hyperandrogenism in PCOS via melatonin receptor 1A and aromatase reduction. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Rüdiger Hardeland. (2022) Redox Biology of Melatonin: Discriminating Between Circadian and Noncircadian Functions. Antioxidants & Redox Signaling 37:10-12, pages 704-725.
Crossref
Crossref
Ji Hoon Kim, Kyeongjin Kim & Hyo-Eon Jin. (2022) Three-Dimensional Printing for Oral Pharmaceutical Dosage Forms. Journal of Pharmaceutical Investigation 52:3, pages 293-317.
Crossref
Crossref
Phillip T. Yuhas. (2022) Non-24-Hour Sleep–Wake Disorder and Tasimelteon: A Review for Practitioners Who Work With Blind People. Journal of Visual Impairment & Blindness 116:1, pages 70-84.
Crossref
Crossref
M.S. Petronek, J.M. Stolwijk, S.D. Murray, E.J. Steinbach, Y. Zakharia, G.R. Buettner, D.R. Spitz & B.G. Allen. (2021) Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy. Redox Biology 42, pages 101864.
Crossref
Crossref
Rüdiger Hardeland. (2021) Divergent Importance of Chronobiological Considerations in High- and Low-dose Melatonin Therapies. Diseases 9:1, pages 18.
Crossref
Crossref
Rüdiger Hardeland. 2021. Sirtuin Biology in Medicine. Sirtuin Biology in Medicine
137
151
.
David Mantle, Marcel Smits, Myrthe Boss, Irene Miedema & Inge van Geijlswijk. (2020) Efficacy and safety of supplemental melatonin for delayed sleep–wake phase disorder in children: an overview. Sleep Medicine: X 2, pages 100022.
Crossref
Crossref
Enrico Moretti, Gaia Favero, Luigi Fabrizio Rodella & Rita Rezzani. (2020) Melatonin’s Antineoplastic Potential Against Glioblastoma. Cells 9:3, pages 599.
Crossref
Crossref
Marija Delaš Aždajić, Robert Likić, Stjepan Aždajić, Mirna Šitum, Ivana Lovrić & Danijela Štimac Grbić. (2019) Outpatient benzodiazepine utilization in Croatia: drug use or misuse. International Journal of Clinical Pharmacy 41:6, pages 1526-1535.
Crossref
Crossref
Pedro Merino. 2019. Chemical Biology of Neurodegeneration. Chemical Biology of Neurodegeneration
227
247
.
Glenn Gunzelmann, Stephen M. James & Jo Lynn Caldwell. 2019. Sleep Deprivation and Cognition. Sleep Deprivation and Cognition
177
204
.
Rui Guan & Roneil G. Malkani. 2019. Allergy and Sleep. Allergy and Sleep
367
384
.
Ziqing Li, Yu Zhang, Yuanping Wang, Xia Yan & Pingchang Xie. (2018) Electroacupuncture for primary insomnia. Medicine 97:27, pages e11063.
Crossref
Crossref
Rüdiger Hardeland. (2017) Melatonergic Sleep Promotion: Fundamental Chronobiological Issues Concerning Sleep Onset and Maintenance, Dose and Duration of Action. Sleep and Vigilance 2:1, pages 5-11.
Crossref
Crossref
Gregory M. Brown, Roger S. McIntyre, Joshua Rosenblat & Rüdiger Hardeland. (2018) Depressive disorders: Processes leading to neurogeneration and potential novel treatments. Progress in Neuro-Psychopharmacology and Biological Psychiatry 80, pages 189-204.
Crossref
Crossref
Rüdiger Hardeland. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Sung-Phil Kim, Joo-Hee Kim, Bo-Kyung Kim, Hyeong-Jun Kim, In Chul Jung, Jung Hyo Cho, Jung-Eun Kim, Mi-Kyung Kim, O-Jin Kwon, Ae-Ran Kim, Hyo-Ju Park & Bok-Nam Seo. (2017) Electroacupuncture for insomnia disorder: study protocol for a randomized controlled trial. Trials 18:1.
Crossref
Crossref
Andrew C. Forrestel, Susanne U. Miedlich, Michael Yurcheshen, Steven D. Wittlin & Michael T. Sellix. (2016) Chronomedicine and type 2 diabetes: shining some light on melatonin. Diabetologia 60:5, pages 808-822.
Crossref
Crossref
P. Pévet. 2017. Reference Module in Neuroscience and Biobehavioral Psychology. Reference Module in Neuroscience and Biobehavioral Psychology.
Rüdiger Hardeland. 2017. Hormones in Ageing and Longevity. Hormones in Ageing and Longevity
209
242
.
Jing Yang, Hui Juan Jin, Elisabeth Mocaër, Laure Seguin, Hua Zhao & Benjamin Rusak. (2016) Agomelatine affects rat suprachiasmatic nucleus neurons via melatonin and serotonin receptors. Life Sciences 155, pages 147-154.
Crossref
Crossref
Huimin Zhao, Yifei Wang, Yi Jin, Shu Liu, Haiyan Xu & Xiumei Lu. (2016) Rapid and sensitive analysis of melatonin by LC-MS/MS and its application to pharmacokinetic study in dogs. Asian Journal of Pharmaceutical Sciences 11:2, pages 273-280.
Crossref
Crossref
Rüdiger Hardeland. (2016) Melatonergic Treatment: Focus on Metabolism and Chronobiology. Focus on Sciences 2:1, pages 1-10.
Crossref
Crossref
Sinan Canpolat, Nazife Ulker, Ahmet Yardimci, Ozgur Bulmus, Gokcen Ozdemir, Zafer Sahin, Zubeyde Ercan, Ihsan Serhatlioglu, Emine Kacar, Mete Ozcan, Gaffari Turk, Yusuf Ozkan, Murad Atmaca, Bayram Yilmaz & Haluk Kelestimur. (2016) Studies on the reproductive effects of chronic treatment with agomelatine in the rat. European Journal of Pharmacology 770, pages 33-39.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
65
76
.
Eva Ramos, Paloma Patiño, José Luis Marco-Contelles, Ramón Cacabelos & Alejandro Romero. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy
91
99
.
Agata Carpentieri, Vanessa Areco, Gabriela Díaz de Barboza, María Angélica Rivoira, Solange Guizzardi & Nori Tolosa de Talamoni. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy
55
64
.
Rüdiger Hardeland. 2016. Inflammation, Aging, and Oxidative Stress. Inflammation, Aging, and Oxidative Stress
345
376
.
Valentina Vengeliene, Hamid R Noori & Rainer Spanagel. (2015) Activation of Melatonin Receptors Reduces Relapse-Like Alcohol Consumption. Neuropsychopharmacology 40:13, pages 2897-2906.
Crossref
Crossref
Maria Bonmati-Carrion, Raquel Arguelles-Prieto, Maria Martinez-Madrid, Russel Reiter, Ruediger Hardeland, Maria Rol & Juan Madrid. (2014) Protecting the Melatonin Rhythm through Circadian Healthy Light Exposure. International Journal of Molecular Sciences 15:12, pages 23448-23500.
Crossref
Crossref
Jessica D. Johnsa & Michael W. Neville. (2014) Tasimelteon. Annals of Pharmacotherapy 48:12, pages 1636-1641.
Crossref
Crossref
Rüdiger Hardeland. 2014. Melatonin. Melatonin
11
18
.
Moshe Laudon & Anat Frydman-Marom. (2014) Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders. International Journal of Molecular Sciences 15:9, pages 15924-15950.
Crossref
Crossref
Darius. P. Zlotos, Ralf Jockers, Erika Cecon, Silvia Rivara & Paula A. Witt-Enderby. (2013)
MT
1
and MT
2
Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential
. Journal of Medicinal Chemistry 57:8, pages 3161-3185.
Crossref
Crossref
Darius P. Zlotos. 2014. Melatonin and Melatonergic Drugs in Clinical Practice. Melatonin and Melatonergic Drugs in Clinical Practice
97
116
.
Lindsay T. Fourman & B. Robert Meyer. (2013) Autoimmune Hepatitis in Association With Ramelteon. Journal of Clinical Gastroenterology 47:7, pages 651-654.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2013) Melatonin prolonged release: a guide to its use in the treatment of insomnia in patients aged ≥55 years. Drugs & Therapy Perspectives 29:5, pages 125-129.
Crossref
Crossref
Stefano Comai, Rafael Ochoa-Sanchez & Gabriella Gobbi. (2013) Sleep–wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice. Behavioural Brain Research 243, pages 231-238.
Crossref
Crossref
Emilie Clay, Bruno Falissard, Nicholas Moore & Mondher Toumi. (2012) Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries. European Journal of Clinical Pharmacology 69:4, pages 1-10.
Crossref
Crossref
Rüdiger Hardeland. (2013) Chronobiology of Melatonin beyond the Feedback to the Suprachiasmatic Nucleus—Consequences to Melatonin Dysfunction. International Journal of Molecular Sciences 14:3, pages 5817-5841.
Crossref
Crossref
Hee Yeon ChoiWeon-Jeong Lim. (2013) Current Clinical Practice of Insomnia. The Ewha Medical Journal 36:2, pages 84.
Crossref
Crossref
P. Pévet. 2013. Encyclopedia of Sleep. Encyclopedia of Sleep
442
445
.
Katherine A. Lyseng-Williamson. (2012) Melatonin Prolonged Release. Drugs & Aging 29:11, pages 911-923.
Crossref
Crossref
A. Carpentieri, G. Díaz de Barboza, V. Areco, M. Peralta López & N. Tolosa de Talamoni. (2012) New perspectives in melatonin uses. Pharmacological Research 65:4, pages 437-444.
Crossref
Crossref
Rüdiger Hardeland, Juan Antonio Madrid, Dun-Xian Tan & Russel J. Reiter. (2012) Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. Journal of Pineal Research 52:2, pages 139-166.
Crossref
Crossref
Mohamed Ettaoussi, Ahmed Sabaouni, Marouan Rami, Jean A. Boutin, Philippe Delagrange, Pierre Renard, Michael Spedding, Daniel-Henri Caignard, Pascal Berthelot & Saïd Yous. (2012) Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I). European Journal of Medicinal Chemistry 49, pages 310-323.
Crossref
Crossref
M.A. Quera SalvaS. Hartley. (2012) Mood Disorders, Circadian Rhythms, Melatonin and Melatonin Agonists. Journal of Central Nervous System Disease 4, pages JCNSD.S4103.
Crossref
Crossref
David N. Neubauer. 2012. Therapy in Sleep Medicine. Therapy in Sleep Medicine
172
180
.
Sohil A. Khan, Helen Heussler, Treasure McGuire, Carolyn Dakin, David Pache, Ross Norris, David Cooper & Bruce Charles. (2011) Therapeutic Options in the Management of Sleep Disorders in Visually Impaired Children: A Systematic Review. Clinical Therapeutics 33:2, pages 168-181.
Crossref
Crossref
Lucia Sukys-Claudino, Walter André dos Santos Moraes, Sergio Tufik & Dalva Poyares. (2010) Novos sedativos hipnóticos. Revista Brasileira de Psiquiatria 32:3, pages 288-293.
Crossref
Crossref
Marta Garaulet & Juan Antonio Madrid. (2010) Chronobiological aspects of nutrition, metabolic syndrome and obesity. Advanced Drug Delivery Reviews 62:9-10, pages 967-978.
Crossref
Crossref
Rüdiger Hardeland. (2009) Neuroprotection by Radical Avoidance: Search for Suitable Agents. Molecules 14:12, pages 5054-5102.
Crossref
Crossref